Acumen Pharmaceuticals, Inc. (ABOS) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TARA
Protara Therapeutics, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ABOS vs TARA
growth of $100 · dividends reinvested · last 5yABOS -89.4% (-36.2%/yr)TARA -71.7% (-22.3%/yr)TARA compounded faster over this window
ABOS TARA
ABOS vs TARA: by the numbers
- •ABOS is the larger company ($147M vs $144M market cap).
Metrics side by side
Valuation
| Metric | ABOS | TARA |
|---|---|---|
| P/B ratio | 2.56 | 0.89 |
Profitability
| Metric | ABOS | TARA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -183.44% | -43.40% |
| ROIC | -118.67% | -47.18% |
Growth (annualized)
| Metric | ABOS | TARA |
|---|---|---|
| Total return CAGR (5Y) | -32.60% | -16.45% |
Frequently asked
- How have ABOS and TARA total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and TARA delivered -16.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.